Tudriqev

Product NDC
83616-106
11-digit product format
836160106
Labeler code
83616
Product ID
83616-106_1ddc4551-7fe8-4d58-952c-1d0dd1f6af67
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
vusolimogene oderparepvec-wtpg
Dosage form
INJECTION, SUSPENSION
Route
INTRATUMOR
Labeler
Replimune, Inc.
Application
BLA125827
Marketing category
BLA
Marketing start
2026-09-04
Substance
VUSOLIMOGENE ODERPAREPVEC
Active strength
1000000 [PFU]/mL
NDC exclude flag
No
Listing certified through
2027-12-31
Current FDA listing
Yes

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Tudriqev
Listing expiration
2027-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
VUSOLIMOGENE ODERPAREPVEC1000000 [PFU]/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
45KLN7N6UVInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 4 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
2751862Internal RxNorm lookup
2751869Internal RxNorm lookup
2751872Internal RxNorm lookup
2751875Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
26627b8d-91ac-4f76-a213-7e25efd024d1Available on FDA.report

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TudriqevVUSOLIMOGENE ODERPAREPVEC-WTPGReplimune, Inc.26627b8d-91ac-4f76-a213-7e25efd024d12026-08-17Warnings, Adverse reactionsExact identifier
application number: BLA125827
ndc (product): 83616-106

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125827TUDRIQEVvusolimogene oderparepvec-wtpg351(a)Rx2026-10-01

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startSampleExclude flagStatus
83616-106-11836160106111 VIAL, SINGLE-DOSE in 1 CARTON (83616-106-11) / 1 mL in 1 VIAL, SINGLE-DOSE (83616-106-01) 2026-09-04NoNoCurrent